Olive
Olive was a healthcare AI company that offered automation solutions for administrative workflows like revenue cycle and prior authorization.
Secondary Market Price
How Olive Measures Up
To help you manage your Olive equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series H
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Olive's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Olive Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Olive's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Olive AI was a healthcare-focused artificial intelligence and process automation company that ceased operations in 2023. Founded in 2012 and headquartered in Columbus, Ohio, the company developed solutions to automate administrative and operational tasks within healthcare organizations. Its services included revenue cycle automation, claims management, and prior authorization, which were designed to reduce administrative errors and improve interoperability between disparate data systems. During its operation, Olive AI served hundreds of hospitals, raised over $855 million in total funding, and reached a valuation of $4 billion in its final funding round.
As the company is now defunct, there are no recent announcements or future plans. Business data platforms and Olive's own corporate social media pages reflect that the company is closed. The company's LinkedIn page, for example, is no longer active and refers visitors to Waystar, another company in the healthcare technology sector.
- Tiger Global
- General Catalyst
- Drive Capital
- Silicon Valley Bank
- GV
- Sequoia Capital Global Equities
- Dragoneer Investment Group
- Transformation Capital Partners
- Vista Equity Partners
- Base10 Partners
- Co-Founder, Sean Lane
- Co-Founder, Bradley Mascho
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Olive worth joining?
The value of joining a pre-IPO company like Olive depends on your personal career goals and the company's long-term potential. Tools like Prospect can help you understand and maximize the value of your equity compensation, which is a key part of the decision.
What should I do with my Olive stock?
Deciding what to do with your pre-IPO stock involves complex tax and financial planning, including when to exercise options or sell shares. Platforms like Prospect provide personalized strategies and tools to help you make informed decisions and optimize your financial outcome.
Can you sell Olive stock?
Selling stock in a private company like Olive is often possible through company-approved tender offers or on secondary markets, though it is more restricted than selling public stock. Prospect offers tender offer tools to help you determine how much to sell and which shares are the most tax-optimal.
How can I find the value of my Olive stock?
The value of private stock is typically determined by the company's latest 409A valuation, but this may not reflect its current market price. You can get a clearer picture using tools like Prospect's predictive models, which forecast future share value based on venture capital data.
What is Olive's equity worth?
A private company's total equity value is based on its most recent valuation, but the worth of your personal stake depends on your specific grants and the company's future performance. To understand the potential future value of your holdings, you can use financial modeling tools from platforms like Prospect.
What is Olive's stock ticker symbol?
As a private, pre-IPO company, Olive does not have a stock ticker symbol. Ticker symbols are only assigned to companies once they become publicly traded on a stock exchange like the NYSE or NASDAQ.
Can I buy or sell Olive stock?
Selling stock in a private company is sometimes possible through secondary markets or tender offers, while buying is generally restricted to employees or accredited investors. If you are an employee looking to sell, platforms like Prospect offer tools to help you navigate the process and optimize tax implications.
What is the criteria to buy or invest in Olive stock?
Investing in a private company like Olive is typically restricted to accredited investors or employees participating in the company's equity compensation plans. The specific criteria are set by the company and regulated by securities laws.
